Pharmacological specificity is not the same as clinical selectivity.
D003866:Depressive Disorder / Q000134:cerebrospinal fluid / Q000188:drug therapy*; D004311:Double-Blind Method; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000134:cerebrospinal fluid; D008376:Maprotiline / Q000494:pharmacology / Q000627:therapeutic use; D008734:Methoxyhydroxyphenylglycol / Q000134:cerebrospinal fluid; D015031:Zimeldine / Q000494:pharmacology / Q000627:therapeutic use*
D008376:Maprotiline; D015031:Zimeldine; D008734:Methoxyhydroxyphenylglycol; D006897:Hydroxyindoleacetic Acid